Newsroom | 6337 results
Sorted by: Latest
-
poLight ASA Second Quarter Results Build on Momentum from Strategic Investment
TØNSBERG, Norway--(BUSINESS WIRE)--poLight ASA (OSE: PLT) recognized momentum in strategic markets plus market activity derived from the Strategic Investment Agreement in its 2Q results...
-
Former Meta VP Joe O'Keeffe Joins Phosio as Executive Chairman
CORVALLIS, Ore.--(BUSINESS WIRE)--Phosio, a leader in proprietary lens coating materials for lightweight AI-enabled eyewear, today announced that Joe O'Keeffe, who previously served as Vice President of Research at Meta, has joined the company as Executive Chairman. O'Keeffe is widely recognized for display and optics innovation across startups and big tech. At Meta, he led the display and optical systems R&D for next-generation Augmented Reality (AR) glasses, playing a key role in shaping...
-
Fintiv Files RICO and Trade Secret Misappropriation Suit Against Apple Stemming from Alleged Theft of Mobile Wallet Technology Used to Create Apple Pay
AUSTIN, Texas--(BUSINESS WIRE)--Fintiv, Inc., a global leader in patented, digital wallet ecosystems, announced today the filing of a civil lawsuit against Apple, Inc. in the Northern District of Georgia, Atlanta Division, alleging violations of the Racketeer Influenced and Corrupt Organizations (RICO) Act, Georgia's RICO Act, The Defend Trade Secrets Act, and Georgia's Trade Secret Act. The lawsuit, filed by Kasowitz LLP, alleges that Apple engaged in a pattern of racketeering activity, includ...
-
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced financial results for the second quarter ended June 30, 2025, and provided a business update. “Our team continues to be very disciplined about executing our plans and is making strong progress advancing our clinical stage PBGENE-HBV program whil...
-
D-Wave Reports Second Quarter 2025 Results
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in commercial quantum computing systems, software, and services, today announced financial results for its second quarter ended June 30, 2025. “Our second quarter results show consistently strong performance across a multitude of technical and business metrics,” said Dr. Alan Baratz, CEO of D-Wave. “During the quarter, we brought to market our sixth-generation quantum computer, signed a me...
-
Quartz Imaging Launches PCI-AM Version 9 Featuring Groundbreaking Template Matching for Automated Semiconductor Metrology
VANCOUVER, British Columbia--(BUSINESS WIRE)--Quartz Imaging's latest PCI-AM Version 9 for Automated Microscopy Measurements is going to revolutionize the industry...
-
CrowdStrike Signal Delivers the Next Evolution of AI-Powered Threat Detection
AUSTIN, Texas--(BUSINESS WIRE)--Black Hat USA 2025, Las Vegas -- CrowdStrike (NASDAQ: CRWD) today announced the general availability of CrowdStrike Signal, a new class of AI-powered detection engines that surface the undetectable threats others miss – before they escalate. Signal uses self-learning models for every host to understand what’s normal in that environment across time, systems, and users. It pinpoints subtle, early-stage threat activity and connects related behaviors – before traditi...
-
CareFirst BCBS Recognizes Nalu Neurostimulation System as Medically Necessary for Chronic Peripheral Pain, Expanding Access to 3.5 Million Covered Lives
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc., a leader in miniaturized neuromodulation therapies for chronic neuropathic pain, is pleased to announce that CareFirst BCBS has issued an updated medical coverage policy designating the Nalu Neurostimulation System as medically necessary in treatment of chronic pain of peripheral origin. This change, effective August 4th, 2025, follows a review by CareFirst of Nalu clinical data, inclusive of the recently published COMFORT 2 confirmatory ra...
-
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve as a member of the audit committee. Ms. Shineman Blake most recently served as chief executive officer of Vistaprint, a Cimpress company, and brings nearly three decades of experience across multiple strategic areas including corporate governance, customer experience, digit...
-
KIOXIA LC9 Series 245.76 TB Enterprise SSD with Innovative 32-die Stack Memory Named ‘Best of Show’ at FMS: the Future of Memory and Storage 2025
SAN JOSE, Calif.--(BUSINESS WIRE)--KIOXIA’s LC9 Series enterprise SSD has received an FMS ‘Best of Show’ award....